Key result
Percutaneous coronary intervention was associated with a similar rate of major adverse cardiovascular events compared to coronary artery bypass grafting in patients with left main coronary artery disease.
Why the study?
Patients with left main coronary artery disease and a high SYNTAX score were excluded from randomized studies comparing PCI and CABG.
Does percutaneous coronary intervention improve major adverse cardiovascular events compared to coronary artery bypass grafting in patients with left main coronary artery disease?
Observational (n=292)
No
Does percutaneous coronary intervention improve major adverse cardiovascular events compared to coronary artery bypass grafting in patients with left main coronary artery disease?
Answers are grounded in this paper and cite their sources.
Introduction Patients with left main coronary artery disease (LMCAD) with a high SYNTAX score (SS) were excluded from randomized studies that comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). We sought to compare PCI and CABG in the real-world practice and investigate the impact of SS I, SS II, and SS II 2020 on clinical outcomes. Methods In total, 292 Patients with LMCAD (173 PCI, 119 CABG) treated between 2017 and 2021 were enrolled. The primary outcome was major adverse cardiovascular events (MACE), a composite of all-cause death, stroke, or myocardial infarction (MI). Results The mean SS I was high in both groups (PCI vs. CABG: 31.64 ± 11.45 vs. 32.62 ± 11.75, P = 0.660). The primary outcome occurred in 28 patients (16.2%) in the PCI group and in 19 patients (16.0%) in the CABG group without significant difference [adjusted hazard ratio, 95% CI = 0.98 (0.51–1.90), P = 0.97] over the follow-up period (26.9 ± 17.7 months). No significant difference was observed in all-cause mortality (11.6% vs. 11.8%, p = 0.93) or stroke rates (3.5% vs. 5.0%, p = 0.51) between groups. However, PCI was associated with higher MI (4.6% vs. 0.8%, p < 0.05) and revascularization rates (26% vs. 5.9%, p < 0.001). Prognostic value of the SS I, SS II and SS II 2020 on the primary outcome was not relevant in the PCI group. Conclusion Among patients with LMCAD, PCI and CABG did not significantly differ in the composite endpoint of all-cause death, stroke, and MI. These results support the potential expansion of PCI indications in LMCAD management for whom are ineligible for CABG with complex coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Sung et al. (2023) conducted an observational in Left main coronary artery disease (n=292). Percutaneous coronary intervention vs. Coronary artery bypass grafting was evaluated on Major adverse cardiovascular events (composite of all-cause death, stroke, or MI) (adjusted HR 0.98, 95% CI 0.51-1.90, p=0.97). Percutaneous coronary intervention was associated with a similar rate of major adverse cardiovascular events compared to coronary artery bypass grafting in patients with left main coronary artery disease.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: